Bottom line
PRHSX vs PINK: the short answer
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and PINK (Simplify Health Care ETF) share a meaningful slice of their top holdings — about 41% by weight.
But PRHSX is far broader, holding 279 positions to 54 for PINK, so beyond the top names it adds exposure PINK doesn't have.
PINK is cheaper at 0.51% vs 0.83% — a difference of $32 a year per $10,000 invested.
Over one year, PINK returned +24.1% vs +17.7% for PRHSX.
Updated Nov 19, 2026
PRHSX vs PINK side by side
| PRHSX | PINK | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | T. Rowe Price | Simplify Exchange Traded |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.83% | 0.51% |
| Annual cost per $10k | $83 | $51 |
| 10-yr cost on $10k (prospectus) | $1,025 | $641 |
| Max front load | — | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +17.7% | +24.1% |
| 5-yr return (annualized) | +4.2% | — |
| 10-yr return (annualized) | +9.1% | — |
| Best quarter | +23.5% | +15.6% |
| Worst quarter | −15.8% | −9.5% |
| Net assets (fund) | $11.9B | $358.6M |
| Number of holdings | 279 | 54 |
| Portfolio turnover | 62% | 171% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PRHSX | PINK | Difference |
|---|---|---|---|
| 2025 | +17.7% | +24.1% | −6.4% |
| 2024 | +1.8% | +8.9% | −7.1% |
| 2023 | +3.1% | +3.8% | −0.7% |
| 2022 | −12.2% | −4.3% | −7.9% |
Source: Fund prospectus bar charts
Holdings overlap
12 of PRHSX's top 25 holdings also appear in PINK's top 25.
| Holding | PRHSX | PINK |
|---|---|---|
| Eli Lilly & Co | 14.28% | 5.91% |
| Johnson & Johnson | 6.63% | 5.45% |
| Unitedhealth Group Inc | 5.99% | 5.76% |
| Abbvie Inc | 5.10% | 4.52% |
| Gilead Sciences Inc | 2.82% | 2.87% |
| Thermo Fisher Scientific Inc | 2.52% | 3.23% |
| Vertex Pharmaceuticals Inc | 2.28% | 1.45% |
| Amgen Inc | 1.82% | 2.12% |
| Elevance Health Inc | 1.53% | 2.73% |
| Danaher Corp | 1.43% | 2.28% |
| Cardinal Health Inc | 1.03% | 1.78% |
| Cvs Health Corp | 0.94% | 2.01% |
Source: SEC Form N-PORT
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
PINK top 10
- Purecycle Technologies Inc — 6.89%
- United Therapeutics Corp — 6.86%
- Novo Nordisk A/s — 6.75%
- Eli Lilly & Company — 5.91%
- Unitedhealth Group Inc — 5.76%
- Warby Parker Inc — 5.46%
- Johnson & Johnson — 5.45%
- Jazz Pharmaceuticals Plc — 4.61%
- Abbvie Inc — 4.52%
- Biohaven Ltd — 4.32%
FAQ
What is the difference between PRHSX and PINK?
Which is cheaper, PRHSX or PINK?
Should I own both PRHSX and PINK?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.